You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 277 No. 2, January 8, 1997 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Clinical Investigation
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati
What's this?

Development of Donor-Derived Prostate Cancer in a Recipient Following Orthotopic Heart Transplantation

Evan Loh, MD; Fergus J. Couch, PhD; Carrie Hendricksen; Linda Farid, MD; Paul F. Kelly, MD; Michael A. Acker, MD; John E. Tomaszewski, MD; S. Bruce Malkowicz; Barbara L. Weber, MD

JAMA. 1997;277(2):133-137.


Abstract

Objective.
—To report the development of metastatic prostate cancer in a heart transplant recipient without a primary focus in the recipient prostate gland; to present genetic evidence suggesting transplantation of the malignancy from the donor.

Design.
—Histological analysis of donor prostate and recipient prostate and rib. Molecular genetic analysis of prostate and kidney tissue from the donor and peripheral blood leukocytes and rib tissue from the transplant recipient.

Setting.
—University of Pennsylvania Medical Center.

Results.
—Multiple biopsies of recipient prostate were negative for malignancy but recipient rib contained prostatic adenocarcinoma with osteoblastic bone response. Molecular genetic analysis of recipient rib specimen, which contained both histologically normal and neoplastic cells, was shown to contain a combination of alíeles from the donor and recipient at 4 loci.

Conclusion.
—Although this is a single case report of an uncommon event, genotyping of polymorphic dinucleotide repeat elements from 4 different chromosomal regions provides strong evidence that the tumor cells arose from donor tissue and were transplanted along with the cardiac allograft.



Author Affiliations

From the Departments of Medicine (Drs Loh, Couch, Kelly, and Weber, and Ms Hendricksen), Pathology (Drs Farid and Tomaszewski), Surgery (Drs Acker and Malkowicz), and Genetics (Dr Weber), University of Pennsylvania School of Medicine, Philadelphia.


Footnotes

Reprints: Barbara L. Weber, MD, Stellar Chance Laboratories, University of Pennsylvania, 422 Curie Blvd. Room 1009, Philadelphia, PA 19104.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Circulating Tumor Cells in Metastatic Breast Cancer -- Toward Individualized Treatment?
Braun and Marth
NEJM 2004;351:824-826.
FULL TEXT  

Prostate Cancer Transmitted in an Orthotopic Heart Transplant
Kohr
JAMA 1997;277:1354-1354.
ABSTRACT  

Prostate Cancer Transmitted in an Orthotopic Heart Transplant
Pretorius and Wurnig
JAMA 1997;277:1355-1355.
ABSTRACT  

Prostate Cancer Transmitted in an Orthotopic Heart Transplant
Pollack
JAMA 1997;277:1354-1354.
ABSTRACT  

Prostate Cancer Transmitted in an Orthotopic Heart Transplant
Schloerb
JAMA 1997;277:1355-1355.
ABSTRACT  

PROSTATE CANCER TRANSMITTED VIA HEART TRANSPLANTATION
JWatch General 1997;1997:6-6.
FULL TEXT  

Tumors Arising After Organ Transplantation: Sorting Out Their Origins
Gazdar
JAMA 1997;277:154-155.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1997 American Medical Association. All Rights Reserved.